These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conditional approval: Japan lowers the bar for regenerative medicine products. Sipp D Cell Stem Cell; 2015 Apr; 16(4):353-6. PubMed ID: 25842975 [TBL] [Abstract][Full Text] [Related]
5. The global cell therapy industry continues to rise during the second and third quarters of 2012. Mason C; McCall MJ; Culme-Seymour EJ; Suthasan S; Edwards-Parton S; Bonfiglio GA; Reeve BC Cell Stem Cell; 2012 Dec; 11(6):735-9. PubMed ID: 23217418 [TBL] [Abstract][Full Text] [Related]
6. Industry highlights: Stem cell and regenerative medicine. Ilic D Regen Med; 2011 Nov; 6(6 Suppl):55-60. PubMed ID: 21999262 [No Abstract] [Full Text] [Related]
9. FDA challenges stem-cell clinic. Cyranoski D Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009 [No Abstract] [Full Text] [Related]
10. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench. Grabel L J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of pluripotent stem cells for regenerative medicine. Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367 [TBL] [Abstract][Full Text] [Related]
12. The new explorations of the neurorestorative process: a brief introduction to the IANR special issue. Huang H Cell Transplant; 2014; 23 Suppl 1():S1-3. PubMed ID: 25375975 [No Abstract] [Full Text] [Related]
13. An embryonic nation. Yang X Nature; 2004 Mar; 428(6979):210-2. PubMed ID: 15014509 [No Abstract] [Full Text] [Related]
14. The World Stem Cell Summit. Interview with Bernard Siegel. Siegel B Regen Med; 2011 Nov; 6(6 Suppl):109-12. PubMed ID: 21999271 [TBL] [Abstract][Full Text] [Related]